Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jan;68(1):172-175.
doi: 10.1016/j.amepre.2024.08.018. Epub 2024 Aug 31.

Social Vulnerability and National Diabetes Prevention Program Recognition Status

Taynara Formagini  1 , Daphnee Rodriguez  2 , Ariba Rezwan  3 , Jeanean B Naqvi  4 , Matthew James O'Brien  5 , Boon Peng Ng  6
Affiliations

Social Vulnerability and National Diabetes Prevention Program Recognition Status

Taynara Formagini et al. Am J Prev Med. 2025 Jan.

Abstract

Introduction: The CDC National Diabetes Prevention Program (National DPP) aims to reduce the incidence of type 2 diabetes in the U.S. Organizations delivering the National DPP receive pending, preliminary, full, or full-plus recognition status based on specific program criteria and outcomes. Achieving full/full-plus recognition is critical for organizations to sustain the program and receive reimbursements to cover costs, but organizations in disadvantaged areas may face barriers to obtaining this level of recognition. This study examined the association between county-level social vulnerability and full/full-plus recognition status within the National DPP.

Methods: Using the 2022 National DPP registry and the 2018 CDC Social Vulnerability Index (SVI), a three-level categorical dependent variable was created (n=843): counties without organizations having full/full-plus recognition, counties with at least one organization not having full/full-plus recognition, and counties with all organizations having full/full-plus recognition. A multinomial logit model was analyzed in 2023 to examine the association between SVI and in-person full/full-plus recognition organizations at the county level, adjusting for confounders.

Results: Compared to counties with low social vulnerability, counties with higher social vulnerability had significantly higher odds of having no organizations with full/full-plus recognition. For example, counties with high SVI had 2.63 (95% CI: 1.55-4.47) times higher odds of having no organizations with full/full-plus recognition compared to having all organizations with full/full-plus CDC recognition.

Conclusions: The findings suggest disparities in the National DPP recognition status among organizations in vulnerable communities. Developing strategies to ensure organizations in high social vulnerability areas achieve at least full recognition status is critical for program sustainability and reducing diabetes-related health disparities.

PubMed Disclaimer

Conflict of interest statement

Declaration of interest: None to declare.

References

    1. Albright AL, Gregg EW. Preventing type 2 diabetes in communities across the US: the National Diabetes Prevention Program. Am J Prev Med. 2013;44(4):S346–S351. 10.1016/j.amepre.2012.12.009. - DOI - PMC - PubMed
    1. Centers for Disease Control Prevention (CDC). Diabetes Prevention Recognition Program Standards and Operating Procedures (English & Spanish). 2021. Accessed August 23, 2024. https://nationaldppcsc.cdc.gov/s/article/DPRP-Standards-and-Operating-Pr...
    1. Centers for Medicare & Medicaid Services. Medicare Diabetes Prevention Program (MDPP) expanded model. Accessed December 20, 2023. https://www.cms.gov/priorities/innovation/innovation-models/medicare-dia...
    1. National Association of Chronic Disease Directors. National DPP coverage toolkit—Medicaid coverage. Accessed December 20, 2023. https://coveragetoolkit.org/medicaid-agencies/medicaid-coverage-2/
    1. Ritchie ND, Gritz RM. New Medicare diabetes prevention coverage may limit beneficiary access and widen health disparities. Med Care. 2018;56(11):908–911. 10.1097/MLR.0000000000000981. - DOI - PubMed